T2DM—will tertiary prevention solve the problem?

被引：0
|
作者：
Adrian Bauman
Alexis St George
机构：
[1] Prevention Research Collaboration,
[2] School of Public Health,undefined
[3] Building K25,undefined
[4] University of Sydney,undefined
来源：
Nature Reviews Endocrinology | 2013年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Gregg et al. demonstrate small but significant remission rates for type 2 diabetes mellitus (T2DM), achieved through an intensive lifestyle tertiary prevention trial. This finding reinforces existing evidence from intensive secondary prevention trials. But can these programmes be translated into the community with similar effects, or is primary prevention required to reduce the epidemic of T2DM?
引用
收藏
页码：190 / 192
页数：2
相关论文
共 50 条
  • [21] Perspectives on T2DM from Clinicians and from People With T2DM in China: The EXPLORE Global Survey
    Yu, Xuefeng
    Wens, Johan
    Felton, Anne M.
    Islas, Ayeza Bonilla
    Schwarz, Peter E. H.
    Cobble, Michael E.
    DIABETES, 2013, 62 : A214 - A214
  • [22] Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM)
    Souto, Selma B.
    Souto, Eliana B.
    Braga, Daniel C.
    Medina, Jose L.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (07) : 653 - 661
  • [23] Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype
    Matthew D. Campbell
    Thirunavukkarasu Sathish
    Paul Z. Zimmet
    Kavumpurathu R. Thankappan
    Brian Oldenburg
    David R. Owens
    Jonathan E. Shaw
    Robyn J. Tapp
    Nature Reviews Endocrinology, 2020, 16 : 395 - 400
  • [24] Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM)
    Selma B. Souto
    Eliana B. Souto
    Daniel C. Braga
    José L. Medina
    European Journal of Clinical Pharmacology, 2011, 67 : 653 - 661
  • [25] Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype
    Campbell, Matthew D.
    Sathish, Thirunavukkarasu
    Zimmet, Paul Z.
    Thankappan, Kavumpurathu R.
    Oldenburg, Brian
    Owens, David R.
    Shaw, Jonathan E.
    Tapp, Robyn J.
    NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (07) : 395 - 400
  • [26] Insulin Secretion and Sensitivity Pattern Is Different in patients With T2DM Only or Patients With T2DM and NAFLD
    Pan, Xiaoyu
    Liu, Qing
    Song, Kexiu
    Chai, Shangyu
    Li, Fei
    Huang, Yueye
    Bhavna, Bhavna
    Jhummon, Navina Priya
    Qu, Shen
    DIABETES, 2013, 62 : A492 - A492
  • [27] PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN T2DM PATIENTS TERTIARY CARE HOSPITAL IN INDIA
    Raval, A. D.
    Dhanaraj, E.
    Bhansali, A.
    VALUE IN HEALTH, 2011, 14 (03) : A100 - A101
  • [28] T2DM treatment trial results
    Claire Greenhill
    Nature Reviews Endocrinology, 2019, 15 : 499 - 499
  • [29] Mechanisms of hyperhomocysteinemia in T2DM with nephropathy
    Tessari, P
    Coracina, A
    Kiwanuka, E
    Vedovato, M
    Vettore, M
    Valerio, A
    Garibotto, G
    DIABETOLOGIA, 2005, 48 : A376 - A377
  • [30] Defining genetic risk of T2DM
    Claire Greenhill
    Nature Reviews Endocrinology, 2019, 15 : 438 - 438
12345